(Q45450320)

English

Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results

scientific article published in July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

liver cirrhosis

0 references

1 reference

based on heuristic

inferred from title

liver transplantation

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Teresa C Taltavull

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nadia Chahri

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Blanca Verdura

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Joan Gornals

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Carmen Lopez

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Aurora Casanova

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Concha Cañas

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Juan Figueras

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Luis A Casais

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

879-883

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Management of patients with decompensated HBV cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Octreotide ameliorates the increase in collateral blood flow during postprandial hyperemia in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00125.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2005.00125.X

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45450320&oldid=2076960916"